» Articles » PMID: 30002604

Vasodilator-stimulated Phosphoprotein (VASP), a Novel Target of MiR-4455, Promotes Gastric Cancer Cell Proliferation, Migration, and Invasion, Through Activating the PI3K/AKT Signaling Pathway

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2018 Jul 14
PMID 30002604
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MicroRNAs (miRNAs) are small non-coding RNAs which play important roles in the carcinogenesis of gastric cancer (GC). Expression profiling of miRNAs in paired gastric cancer and adjacent normal gastric tissues has demonstrated that miR-4455 is down-regulated in gastric cancer tissues, but its functional role in the carcinogenesis of GC had not previously been investigated.

Aims: The purpose of this study was to investigate the functional and biological mechanisms of miR-4455 in the progression of GC, in vitro.

Methods: Expression of miR-4455 was compared in human GC tissue samples and paired adjacent normal tissue samples. The in vitro effects of miR-4455 expression in MGC-803 cells on their proliferation, invasion, and migration were assessed by MTT assays and 5-bromo-2'-deoxyuridine staining, matrigel-invasion analysis and wound healing assays. Bioinformatics analysis (using PicTar, target scan and miRBase target) was used to identify potential targets for miR-4455, and the luciferase reporter assay, qRT-PCR and Western-blotting analyses were used to confirm VASP as the target of miR-4455. In addition, the effects of downregulation of VASP on the activation of PI3K/AKT signaling pathway were measured using Western-blot analysis.

Results: The expression of miR-4455 was markedly down-regulated in gastric cancer tissues vs. adjacent normal tissues, and miR-4455 expression inhibited the proliferation, invasion and migration of MGC-803 GC cells in vitro. Luciferase reporter assays revealed that miR-4455 inhibited VASP expression by targeting the 3'-UTR sequence of VASP. Furthermore, silencing of VASP markedly inhibited the activation of the PI3K/AKT signaling pathway.

Conclusion: Our results suggest that miR-4455 functions as a tumor suppressor in gastric cancer, by targeting VASP leading to activation of the PI3K/AKT signaling pathway and the inhibition of VASP mediated proliferation, migration and invasion of gastric cancer cells.

Citing Articles

Comprehensive serum proteomics profiles and potential protein biomarkers for the early detection of advanced adenoma and colorectal cancer.

Tan C, Qin G, Wang Q, Li K, Zhou Y, Yao S World J Gastrointest Oncol. 2024; 16(7):2971-2987.

PMID: 39072170 PMC: 11271786. DOI: 10.4251/wjgo.v16.i7.2971.


LINC01535 promotes hepatocellular carcinoma proliferation and metastasis by regulating the miR-214-3p/VASP axis.

Liu C, Li K, Ding W, Tang X, Wu Z, Zhu X J Cancer. 2024; 15(12):3809-3824.

PMID: 38911365 PMC: 11190762. DOI: 10.7150/jca.91756.


The Role of Vasodilator-stimulated Phosphoproteins in the Development of Malignant Tumors.

Gui J, Zhou H, Wan H, Yang D, Liu Q, Zhu L Curr Cancer Drug Targets. 2023; 24(5):477-489.

PMID: 37962042 PMC: 11092557. DOI: 10.2174/0115680096262439231023110106.


Mesangial Cell-Derived Exosomal miR-4455 Induces Podocyte Injury in IgA Nephropathy by Targeting ULK2.

Yu M, Shen X, He W, Zheng D, He Q, Jin J Oxid Med Cell Longev. 2022; 2022:1740770.

PMID: 36388165 PMC: 9652064. DOI: 10.1155/2022/1740770.


Cytoskeletal and Cytoskeleton-Associated Proteins: Key Regulators of Cancer Stem Cell Properties.

Li Y, Wang D, Ge H, Gungor C, Gong X, Chen Y Pharmaceuticals (Basel). 2022; 15(11).

PMID: 36355541 PMC: 9698833. DOI: 10.3390/ph15111369.


References
1.
Shen C, Song Y, Xie Y, Wang X, Wang Y, Wang C . Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway. Oncotarget. 2017; 8(44):76279-76289. PMC: 5652705. DOI: 10.18632/oncotarget.19348. View

2.
Nawaz M . Extracellular vesicle-mediated transport of non-coding RNAs between stem cells and cancer cells: implications in tumor progression and therapeutic resistance. Stem Cell Investig. 2017; 4:83. PMC: 5676198. DOI: 10.21037/sci.2017.10.04. View

3.
Kao H, Pan C, Lai C, Wu C, Fang W, Huang K . Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer. Oncotarget. 2017; 8(34):56389-56397. PMC: 5593569. DOI: 10.18632/oncotarget.16916. View

4.
Zhang L, Zhang L, Guo X, Zhang D, Yang F, Fan Y . Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion. DNA Cell Biol. 2017; 37(1):46-52. DOI: 10.1089/dna.2017.3926. View

5.
Tan B, Li Y, Di Y, Fan L, Zhao Q, Liu Q . Clinical value of peripheral blood microRNA detection in evaluation of SOX regimen as neoadjuvant chemotherapy for gastric cancer. J Clin Lab Anal. 2017; 32(4):e22363. PMC: 6817264. DOI: 10.1002/jcla.22363. View